G6PD and lung carcinoma: Many previous studies support that an increased level of G6PD could be a hallmark of cisplatin resistance in lung cancer, which is in line with our data (G6PD; logFC: 2.901803, p.value: 1.82E‐14).35, 41, 42, 43, 44